vs
Side-by-side financial comparison of ACME UNITED CORP (ACU) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $52.3M, roughly 1.6× ACME UNITED CORP). ACME UNITED CORP runs the higher net margin — 1.9% vs -38.1%, a 39.9% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 13.8%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs -2.9%).
Acme United Corporation is a supplier of cutting, measuring and safety products for the school, home, office, hardware and industrial markets. The company was organized as a partnership in 1867 and incorporated in 1873 under the laws of the State of Connecticut. It is publicly traded on the NYSE American with symbol ACU.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
ACU vs PRCT — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $52.3M | $83.1M |
| Net Profit | $985.0K | $-31.6M |
| Gross Margin | 39.7% | 64.9% |
| Operating Margin | 3.3% | -4.1% |
| Net Margin | 1.9% | -38.1% |
| Revenue YoY | 13.8% | 20.2% |
| Net Profit YoY | -40.4% | -27.9% |
| EPS (diluted) | $0.24 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $52.3M | $83.1M | ||
| Q4 25 | $47.5M | $76.4M | ||
| Q3 25 | $49.1M | $83.3M | ||
| Q2 25 | $54.0M | $79.2M | ||
| Q1 25 | $46.0M | $69.2M | ||
| Q4 24 | $45.9M | $68.2M | ||
| Q3 24 | $48.2M | $58.4M | ||
| Q2 24 | $55.4M | $53.4M |
| Q1 26 | $985.0K | $-31.6M | ||
| Q4 25 | $1.9M | $-29.8M | ||
| Q3 25 | $1.9M | $-21.4M | ||
| Q2 25 | $4.8M | $-19.6M | ||
| Q1 25 | $1.7M | $-24.7M | ||
| Q4 24 | $1.7M | $-18.9M | ||
| Q3 24 | $2.2M | $-21.0M | ||
| Q2 24 | $4.5M | $-25.6M |
| Q1 26 | 39.7% | 64.9% | ||
| Q4 25 | 38.2% | 60.6% | ||
| Q3 25 | 39.1% | 64.8% | ||
| Q2 25 | 41.0% | 65.4% | ||
| Q1 25 | 39.0% | 63.9% | ||
| Q4 24 | 38.7% | 64.0% | ||
| Q3 24 | 38.5% | 63.2% | ||
| Q2 24 | 40.8% | 59.0% |
| Q1 26 | 3.3% | -4.1% | ||
| Q4 25 | 6.1% | -40.6% | ||
| Q3 25 | 6.1% | -27.8% | ||
| Q2 25 | 11.8% | -28.0% | ||
| Q1 25 | 5.3% | -39.7% | ||
| Q4 24 | 5.0% | -28.9% | ||
| Q3 24 | 6.1% | -38.4% | ||
| Q2 24 | 11.5% | -50.3% |
| Q1 26 | 1.9% | -38.1% | ||
| Q4 25 | 3.9% | -39.1% | ||
| Q3 25 | 3.9% | -25.7% | ||
| Q2 25 | 8.8% | -24.7% | ||
| Q1 25 | 3.6% | -35.8% | ||
| Q4 24 | 3.7% | -27.6% | ||
| Q3 24 | 4.6% | -35.9% | ||
| Q2 24 | 8.0% | -48.0% |
| Q1 26 | $0.24 | $-0.56 | ||
| Q4 25 | $0.46 | $-0.54 | ||
| Q3 25 | $0.46 | $-0.38 | ||
| Q2 25 | $1.16 | $-0.35 | ||
| Q1 25 | $0.41 | $-0.45 | ||
| Q4 24 | $0.43 | $-0.34 | ||
| Q3 24 | $0.54 | $-0.40 | ||
| Q2 24 | $1.09 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.2M | $245.6M |
| Total DebtLower is stronger | $33.0M | $51.7M |
| Stockholders' EquityBook value | $116.7M | $347.7M |
| Total Assets | $195.2M | $487.1M |
| Debt / EquityLower = less leverage | 0.28× | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $4.2M | $245.6M | ||
| Q4 25 | $3.6M | $286.5M | ||
| Q3 25 | $5.1M | $294.3M | ||
| Q2 25 | $3.6M | $302.7M | ||
| Q1 25 | $3.4M | $316.2M | ||
| Q4 24 | $6.4M | $333.7M | ||
| Q3 24 | $5.7M | $196.8M | ||
| Q2 24 | $3.8M | $214.1M |
| Q1 26 | $33.0M | $51.7M | ||
| Q4 25 | — | $51.6M | ||
| Q3 25 | — | $51.6M | ||
| Q2 25 | — | $51.5M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
| Q1 26 | $116.7M | $347.7M | ||
| Q4 25 | $117.6M | $365.9M | ||
| Q3 25 | $115.8M | $380.3M | ||
| Q2 25 | $113.7M | $385.8M | ||
| Q1 25 | $108.3M | $389.2M | ||
| Q4 24 | $107.0M | $402.2M | ||
| Q3 24 | $106.3M | $241.2M | ||
| Q2 24 | $104.0M | $251.8M |
| Q1 26 | $195.2M | $487.1M | ||
| Q4 25 | $171.0M | $508.1M | ||
| Q3 25 | $173.0M | $511.5M | ||
| Q2 25 | $170.9M | $513.1M | ||
| Q1 25 | $163.0M | $519.4M | ||
| Q4 24 | $162.2M | $534.0M | ||
| Q3 24 | $165.5M | $374.1M | ||
| Q2 24 | $173.5M | $374.4M |
| Q1 26 | 0.28× | 0.15× | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACU
Segment breakdown not available.
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
